Repligen (RGEN) Lags Q2 Earnings Estimates

Repligen (RGEN) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -7.50%. A quarter ago, it was expected that this drug developer would post earnings of $0.35 per share when it actually produced earnings of $0.39, delivering a surprise of +11.43%.Over the last four quarters, the company ...